senktide has been researched along with ssr 146977 in 1 studies
Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (ssr 146977) | Trials (ssr 146977) | Recent Studies (post-2010) (ssr 146977) |
---|---|---|---|---|---|
292 | 1 | 50 | 5 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Advenier, C; Daoui, S; Emonds-Alt, X; Gueudet, C; Le Fur, G; Maffrand, JP; Michaud, JC; Naline, E; Oury-Donat, F; Pascal, M; Poncelet, M; Proietto, V; SoubriƩ, P; Steinberg, R; Vilain, P | 1 |
1 other study(ies) available for senktide and ssr 146977
Article | Year |
---|---|
Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Topics: Animals; CHO Cells; Cricetinae; Gerbillinae; Guinea Pigs; Humans; Methylurea Compounds; Motor Activity; Neurokinin B; Peptide Fragments; Piperidines; Rabbits; Rats; Receptors, Neurokinin-3; Substance P | 2002 |